Sources | Names Used |
---|---|
CTRPv2 | navitoclax:gemcitabine (1:1 mol/mol) |
PharmacoGx | navitoclax:gemcitabine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DCN | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | NPY5R | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | SRGAP2B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ZNF510 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CEP162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | GRM8 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | FKBP10 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | MAP2K7 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | HSPB7 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
mRNA | CPXM1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |